A detailed history of Deltec Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Deltec Asset Management LLC holds 6,050 shares of LLY stock, worth $5.46 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
6,050
Previous 6,650 9.02%
Holding current value
$5.46 Million
Previous $5.17 Million 5.88%
% of portfolio
1.1%
Previous 1.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$724.87 - $909.04 $434,922 - $545,424
-600 Reduced 9.02%
6,050 $5.48 Million
Q4 2023

Jan 22, 2024

SELL
$525.19 - $619.13 $551,449 - $650,086
-1,050 Reduced 13.64%
6,650 $3.88 Million
Q3 2023

Oct 23, 2023

SELL
$434.7 - $599.3 $173,880 - $239,719
-400 Reduced 4.94%
7,700 $4.14 Million
Q1 2023

Apr 17, 2023

BUY
$310.63 - $364.82 $2.52 Million - $2.96 Million
8,100 New
8,100 $2.78 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $858B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Deltec Asset Management LLC Portfolio

Follow Deltec Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deltec Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Deltec Asset Management LLC with notifications on news.